价格

Laboratorios Liconsa SA

ACTIVE

西班牙Private

概览

试验阶段分布

阶段

试验数

占比

1 期

40.0%

试验状态分布

进行中（未招募）

20.0%

已完成

40.0%

招募中

40.0%

药物批准

按机构分类的批准

EMC

Electronic Medicines Compendium

药物批准

PHILIPPINES

Philippines FDA

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

药物批准

近期批准

ESOMEPRAZOL LICONSA 20 MG CAPSULAS DURAS GASTRORRESISTENTES

CIMA_AEMPS

2026-07-02

ESOMEPRAZOL LICONSA 40 MG CAPSULAS DURAS GATRORRESISTENTES

CIMA_AEMPS

2026-07-02

FUMARATO DE DIMETILO LICONSA 240 MG CAPSULAS DURAS GASTRORRESISTENTES EFG

CIMA_AEMPS

2026-05-05

FUMARATO DE DIMETILO LICONSA 120 MG CAPSULAS DURAS GASTRORRESISTENTES EFG

CIMA_AEMPS

2026-05-05

PALIPERIDONA LICONSA 50 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG

CIMA_AEMPS

2025-11-20

PALIPERIDONA LICONSA 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG

CIMA_AEMPS

2025-11-20

PALIPERIDONA LICONSA 25 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG

CIMA_AEMPS

2025-11-20

DABIGATRAN ETEXILATO LABORATORIOS LICONSA 110 MG CAPSULAS DURAS EFG

CIMA_AEMPS

2025-10-14

DABIGATRAN ETEXILATO LABORATORIOS LICONSA 150 MG CAPSULAS DURAS EFG

CIMA_AEMPS

2025-10-14

DABIGATRAN ETEXILATO LABORATORIOS LICONSA 75 MG CAPSULAS DURAS EFG

CIMA_AEMPS

2025-10-14

资讯

暂无资讯文章

返回机构列表

Laboratorios Liconsa SA

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（5）

Bioequivalence Study of Aripiprazole 400 mg Powder and Solvent for Prolonged-Release Suspension for Injection .

A clinical study to determine bioequivalence safety and tolerability of drug called Tiotropium Bromide Inhalation Powder in patients with Chronic Obstructive Pulmonary Disease

A randomized, open-label, multiple dose, four-way crossover pharmacodynamic equivalence study comparingOrlistat 60mg and 120mg hard gelatin capsules in healthyvolunteers.

An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device

Safety and tolerability of medicated chewing gum with sodium alginate, calcium carbonate and sodium bicarbonate.

药物批准

按机构分类的批准

近期批准

资讯